DLX vs TECH · P/E 13, rev $2.12B vs P/E 65, rev $1.22B
Deluxe Corporation (DLX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Deluxe Corporation (DLX) is a conglomerates company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DLX revenue for 2024-12-31 was $2.12B. Net income was $52.9M. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. DLX currently screens at market cap $709.7M and trailing P/E 12.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DLX currently screens at market cap $709.7M and trailing P/E 12.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DLX and TECH stock pages for the full models.
Not investment advice.